Research explained · November 2026
Lose the weight. Keep everything else.
A new randomized trial compared people on tirzepatide who did and didn't strength train. Same weight lost, very different results.
Medically reviewed by Mark Nessim, MD, board-certified anesthesiologist · Last updated
Who publishes this: Habthera Nutrition, which makes ASP-1, a protein supplement. Where our product appears it is labeled as ours. Editorial policy.
The short answer
In a randomized trial published in Nature Medicine on November 10, 2026, adults aged 50 to 70 took tirzepatide for 40 weeks. Half also did resistance training three times a week. Both groups lost about the same amount of weight, roughly 22 kg (about 48 lb). The group that trained lost 25% less lean tissue, and their upper and lower body strength rose about 10%, while strength in the group that didn't train fell about 10%.[1][2]
What the trial did
Putting it to use
More on why muscle loss happens and what protects it: Do GLP-1s cause muscle loss?
It reduces it. In the T-REx randomized trial, adults aged 50 to 70 on tirzepatide who did resistance training three times a week lost 25% less lean tissue than those who didn't, and their strength rose about 10% instead of falling about 10%. They still lost some lean tissue.
The T-REx trial used three resistance training sessions a week. Talk with your doctor before starting if you have heart disease, joint problems or haven't exercised in a long time.
No. Both groups lost about the same amount, roughly 22 kg over 40 weeks. The difference was in what the weight loss was made of, and in strength.
Keep reading